Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement

Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement Publisher

Hashemian S¹ ; Farrokhi R² ; Tabarsi P³ ; Jamaati H¹ ; Velayati A⁴

Source: Biomedical and Biotechnology Research Journal Published:2020

Abstract

COVID-19 pneumonia has rapid development into a global pandemic. For the infected patients, it is an urgent matter to improve the cure rate and reduce the death rate, but there are no effective antiviral drugs for COVID-19 so far. There is an urgent need for effective treatment. The current focus has been on the development of novel therapeutics, including antivirals and vaccines. One of these drugs, Favipiravir (Avigan), an antiviral agent approved for use in influenza in Japan, is being studied for the treatment of COVID-19. Herein, we report a patient; a 53 Y/O man without any underlying disease, developed COVID19 pneumonia rapidly and well respond to combination treatment including Dexamethasone, Favipiravir, and IFN-β-1a. © 2020 Medknow.

Related Docs

View other Related Docs

1. Covid-19: A Review on Treatment Strategies and Candidate Vaccines, Scientific Journal of Kurdistan University of Medical Sciences (2021)

2. Classification of the Present Pharmaceutical Agents Based on the Possible Effective Mechanism on the Covid-19 Infection, DARU# Journal of Pharmaceutical Sciences (2020)

3. Post-Exposure Prophylaxis for Covid-19: A Systematic Review, Infectious Disorders - Drug Targets (2023)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (5)

Zahra Ahmadinejad (2)

Style	Citing Format
MLA	Hashemian S, et al.. "Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement." Biomedical and Biotechnology Research Journal, vol. 4, no. 5, 2020, pp. S93-S95.
APA	Hashemian S, Farrokhi R, Tabarsi P, Jamaati H, Velayati A (2020). Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement. Biomedical and Biotechnology Research Journal, 4(5), S93-S95.
Chicago	Hashemian S, Farrokhi R, Tabarsi P, Jamaati H, Velayati A. "Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement." Biomedical and Biotechnology Research Journal 4, no. 5 (2020): S93-S95.
Harvard	Hashemian S et al. (2020) 'Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement', Biomedical and Biotechnology Research Journal, 4(5), pp. S93-S95.
Vancouver	Hashemian S, Farrokhi R, Tabarsi P, Jamaati H, Velayati A. Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement. Biomedical and Biotechnology Research Journal. 2020;4(5):S93-S95.
BibTex	@article{ author = {Hashemian S and Farrokhi R and Tabarsi P and Jamaati H and Velayati A}, title = {Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement}, journal = {Biomedical and Biotechnology Research Journal}, volume = {4}, number = {5}, pages = {S93-S95}, year = {2020} }
RIS	TY - JOUR AU - Hashemian S AU - Farrokhi R AU - Tabarsi P AU - Jamaati H AU - Velayati A TI - Lifesaving Combined Treatment in a Rapidly Progressive Covid-19 Pneumonia Case With Extensive Lung Involvement JO - Biomedical and Biotechnology Research Journal VL - 4 IS - 5 SP - S93 EP - S95 PY - 2020 ER -

Science Communicator Platform

Authors

Abstract